Finland· FI-REL-REL51160

Semintra

A telmisartan product containing telmisartan, registered in Finland by Boehringer Ingelheim Vetmedica GmbH. The same ATC class is registered in 2 of our 19 countries.

ATC QC09CA07

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedSemintraATCQC09CA07REGISTER NO.FI-REL-REL51160PACKS LISTED0CHECKEDSeptember 27, 2026

Where it is registered

Telmisartan is registered in 2 of 19 countries.

Countries holding a registration under ATC QC09CA07 (telmisartan), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 1 of them publish a price we can compare per daily dose

Telmisartan · ATC QC09CA07

2 / 19 countries

  • Denmark
  • Finlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Fimea (Finland)
Active substance
Telmisartan
Manufacturer
Boehringer Ingelheim Vetmedica GmbH
Country
Finland (FI)
ATC code
QC09CA07
ATC class
telmisartan
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Telmisartan in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All telmisartan products

Authorised across Europe · EMA

The same active substance is authorised in 26 EEA countries. Names it is sold under:

  • Austria · Actelsar, Telmicard
  • Belgium · Telmisartan Eg, Telmisartan Teva
  • Bulgaria · Telsart, Tезео
  • Cyprus · Telmisartan Jubilant
  • Czechia · Telmisartan Egis, Telmisartan Ratiopharm
  • Germany · Telmisartan 1 A Pharma, Telmisartan Abz
  • Denmark · Telmisartan Medical Valley, Telmisartan Stada
  • Estonia · Telmisartaan Amarox, Telmisartan Ratiopharm
  • Spain · Telmark, Telmisartán Almus
  • France · Telmisartan Amarox, Telmisartan Arrow
  • United Kingdom (Northern Ireland) · Telmisartan Accord Healthcare, Telmisartan Amarox
  • Hungary · Tanydon, Telmisartan Egis
  • Ireland · Mirpresoc, Telmisartan Accord Healthcare Ireland
  • Iceland · Kinzalmono, Micardis
  • Italy · Telmisartan Almus, Telmisartan Alter
  • Liechtenstein · Kinzalmono, Micardis
  • Lithuania · Telmisartan Ingen Pharma, Telmisartan Inteli
  • Luxembourg · Telmisartan Eg, Telmisartan Micro Labs
  • Latvia · Telmisartan Ratiopharm, Tezeo
  • Netherlands · Telmisartan 1a Pharma, Telmisartan Amarox
  • Norway · Kinzalmono, Micardis
  • Poland · Actelsar, Polsart
  • Portugal · Diterpris, Mirpresoc
  • Romania · Tezeo
  • Sweden · Telmark, Telmisartan Amarox
  • Slovakia · Telmark, Telmisartan Egis

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/2bdfcfb4-12c4-468b-be1a-4dee4dc52757
GET /v1/drugs/2bdfcfb4-12c4-468b-be1a-4dee4dc52757?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": null,
  "form": "oraaliliuos",
  "route": "Suun kautta",
  "ddd_unit": null,
  "strength": "10 mg/ml",
  "atc_label": "telmisartan",
  "ma_number": null,
  "auth_status": "Myyntilupa myönnetty",
  "eu_ma_number": "EU/2/12/146/003",
  "fimea_rel_id": "REL51160",
  "authorised_at": "2018-05-08"
}

See everything about telmisartan.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.